Literature DB >> 2257436

Zacopride and BRL 24924 induce an increase in EEG-energy in rats.

H W Boddeke1, H O Kalkman.   

Abstract

1. The substituted benzamides, zacopride and BRL 24924 induced dose-dependent increases of the total EEG-energy of rats when applied intracerebroventricularly (i.c.v.) with ED50 values of 8.0 +/- 0.6 and 3.6 +/- 0.9 micrograms, respectively. Not only the energy of the low frequency hippocampal theta rhythm but also that of the other frequency bands was increased. 2. In contrast to i.c.v. application intraperitoneal administration of zacopride or BRL 24924 (1 and 10 mg kg-1) did not lead to an increase in EEG-energy. 3. The increase in EEG-energy induced by zacopride (10 micrograms, i.c.v.) was blocked by ICS 205-930 (1 microgram, i.c.v.). Neither the 5-HT3 receptor agonist 2-methyl-5-hydroxytryptamine (30 micrograms, i.c.v.) nor the selective 5-HT3 receptor antagonist MDL 72222 (30 micrograms, i.c.v.) had any effect upon rat EEG. 4. Scopolamine (0.01 micrograms and 0.1 micrograms, i.c.v.) dose-dependently antagonized the effect of zacopride (10 micrograms, i.c.v.). 5. An agonist action of zacopride and BRL 24924 and inhibition of these effects by ICS 205-930 but not by MDL 72222 was recently described in isolated colliculi neurones from neonatal mice. The receptor involved was described as '5-HT4'. The present results indicate that the central effects of zacopride and BRL 24924 may be due to activation of such a 5-HT receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257436      PMCID: PMC1917704          DOI: 10.1111/j.1476-5381.1990.tb12701.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?

Authors:  D Hoyer; H Gozlan; F Bolanos; L E Schechter; M Hamon
Journal:  Eur J Pharmacol       Date:  1989-11-14       Impact factor: 4.432

2.  BRL 24924: a potent agonist at a non-classical 5-HT receptor positively coupled with adenylate cyclase in colliculi neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

3.  A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930.

Authors:  A Dumuis; R Bouhelal; M Sebben; J Bockaert
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

Review 4.  The 5-HT4 receptor: naughty, but nice.

Authors:  D E Clarke; D A Craig; J R Fozard
Journal:  Trends Pharmacol Sci       Date:  1989-10       Impact factor: 14.819

5.  Cholinomimetics induce theta rhythm and reduce hippocampal pyramidal cell excitability.

Authors:  H R Olpe; K Klebs; E Küng; P Campiche; A Glatt; R Ortmann; F D'Amato; M F Pozza; C Mondadori
Journal:  Eur J Pharmacol       Date:  1987-10-13       Impact factor: 4.432

6.  Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

Authors:  P B Bradley; G Engel; W Feniuk; J R Fozard; P P Humphrey; D N Middlemiss; E J Mylecharane; B P Richardson; P R Saxena
Journal:  Neuropharmacology       Date:  1986-06       Impact factor: 5.250

7.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

Authors:  B P Richardson; G Engel; P Donatsch; P A Stadler
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

8.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Authors:  A Dumuis; R Bouhelal; M Sebben; R Cory; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

9.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

10.  Two kinds of tryptamine receptor.

Authors:  J H GADDUM; Z P PICARELLI
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  1 in total

1.  Ability of 5-HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo.

Authors:  L J Steward; J Ge; R L Stowe; D C Brown; R K Bruton; P R Stokes; N M Barnes
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.